CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,500 target
Drug / intervention
Genetic Analysisgenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01161953
NCT01161953N/ACompleted

Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis (PBC).

Mayo Clinic·observational·Posted Jul 14, 2010·Updated Sep 29, 2025

In Brief

An observational study evaluating Genetic Analysis for Primary Biliary Cirrhosis. Completed, enrolled 1,500 participants across 1 site.

Detailed Summary

Primary Biliary Cirrhosis (PBC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC. This study is being done to investigate whether genes make people more likely to develop PBC. Discovery of these proposed genes will help us better understand how PBC developes, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 14, 2010
Enrollment StartMar 1, 2002
Primary CompletionJul 31, 2025
TodayJul 2, 2026
Enrollment to primary: 23.4 yearsPosted 16.0 years ago

Interventions

Genetic Analysisgenetic

Perform Genome Wide Association Studies.